TY - JOUR T1 - Why Targeting of PSMA Is a Valuable Addition to the Management of Castration-Resistant Prostate Cancer: The Urologist’s Point of View JF - Journal of Nuclear Medicine JO - J Nucl Med SP - 1207 LP - 1209 DO - 10.2967/jnumed.117.194753 VL - 58 IS - 8 AU - Boris A. Hadaschik AU - Martin Boegemann Y1 - 2017/08/01 UR - http://jnm.snmjournals.org/content/58/8/1207.abstract N2 - ER -